Trial Profile
A multicenter real life study evaluating safety and efficacy of sofosbuvir-based regimens in Japanese Hepatitis C patients infected with genotype 1b or 2.
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 08 Jul 2017
Price :
$35
*
At a glance
- Drugs Ledipasvir/sofosbuvir (Primary) ; Ribavirin (Primary) ; Sofosbuvir (Primary)
- Indications Hepatitis C
- Focus Adverse reactions; Therapeutic Use
- 08 Jul 2017 New trial record